Study Reveals Rising Costs for Cancer Patients with Private Insurance

Recent research indicates that a cancer diagnosis significantly raises the monthly out-of-pocket expenses for patients who have private insurance, and these costs tend to increase further as the disease advances.

The study, published in JAMA Open Network, reported that out-of-pocket costs surged by an average of $592.53 per month during the six months following a cancer diagnosis.

This financial burden is particularly concerning for younger individuals with private insurance, who might not yet qualify for Medicare. The report highlights how a cancer diagnosis can impose a serious financial strain, even for those who are insured.

There’s a pressing need for policy reform to help mitigate these costs, the study suggests. It emphasizes the importance of measures like paid sick leave that would address continuity of insurance and provide financial aid, especially for patients facing advanced stages of cancer.

The findings showed that out-of-pocket expenses varied as patients’ cancer progressed. For instance, those diagnosed with stage 0 cancer experienced a cost increase of $462 per month compared to individuals without cancer. In contrast, patients at stage 4 saw their costs rise by an additional $719.97 per month. This escalation in costs is largely due to the increased treatment requirements associated with later-stage cancer.

The research gathered data from medical claims records in the Surveillance, Epidemiology, and End Results (SEER) cancer registry, comparing the expenses of privately insured individuals under 65 diagnosed with breast, colorectal, and lung cancer against their non-cancer counterparts.

Additionally, data from the American Cancer Society highlights that more individuals aged 45-49 are being screened for colon cancer, leading to an uptick in early-stage diagnoses.